ATAI Life Sciences Q2 EPS $(0.14) Misses $(0.12) Estimate, Sales $719.000K Up From $273.000K YoY

Benzinga08-14

ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 61.11 percent increase over losses of $(0.36) per share from the same period last year. The company reported $719.000 thousand in sales this quarter. This is a 163.37 percent increase over sales of $273.000 thousand the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法